Atlas Trials

Hamid Sayar

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hamid Sayar

RecordFirmDate
Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML (NCT02485353)Hamid Sayar2015-10-20
Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype (NCT01534260)Hamid Sayar2012-02-10

Track Hamid Sayar automatically

Every clearance here is in the API, with alerts when new ones post.